Sue Sturrock Selected Research

influenza matrix peptide (58-66)

3/2005	Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination.
7/2003	Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sue Sturrock Research Topics

Disease

4	Melanoma (Melanoma, Malignant) 02/2006 - 07/2003
4	Neoplasms (Cancer) 02/2006 - 07/2003
3	Testicular Neoplasms (Testicular Cancer) 02/2006 - 07/2004
2	Human Influenza (Influenza) 03/2005 - 07/2003
1	Carcinoma (Carcinomatosis) 01/2018
1	Hypersensitivity (Allergy) 07/2004

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 02/2006 - 07/2004
3	MART-1 AntigenIBA 02/2006 - 07/2003
2	Monophenol Monooxygenase (Tyrosinase)IBA 02/2006 - 03/2005
2	influenza matrix peptide (58-66)IBA 03/2005 - 07/2003
2	Peptides (Polypeptides)IBA 03/2005 - 07/2003
1	B7-H1 AntigenIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2006
1	ParaffinIBA 02/2006
1	Differentiation AntigensIBA 02/2006
1	Protein Subunit VaccinesIBA 03/2005
1	EpitopesIBA 07/2004
1	VaccinesIBA 07/2004
1	Interleukin-12 (IL 12)IBA 07/2003

Therapy/Procedure

1	Immunotherapy 02/2006
1	Therapeutics 07/2003